CDKN2A and neoplasm: Strong, diffuse nuclear and cytoplasmic immunohistochemical expression of p16 by tumor cells has been regarded as a surrogate biomarker for high-risk HPV in squamous cell carcinomas of the uterine cervix and oropharynx53,54.